首页> Journal of kidney cancer and VHL> Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials.

Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nathan,Reynolds

第一单位： Department of Internal Medicine, South Pointe Hospital, Cleveland Clinic, Cleveland, OH, USA.

作者： Nathan,Reynolds ^[1] ; Wei,Wei ^[2] ; Kimberly,Maroli ^[3] ; Amanda,Bonham ^[3] ; Amanda,Nizam ^[3] ; Timothy D,Gilligan ^[3] ; Christopher,Wee ^[3] ; Shilpa,Gupta ^[3] ; Moshe C,Ornstein ^[3]

作者单位： Department of Internal Medicine, South Pointe Hospital, Cleveland Clinic, Cleveland, OH, USA. ^[1] Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. ^[2] Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. ^[3]

关键词 clinical trials eligibility criteria immunotherapy kidney cancer renal cell carcinoma

DOI 10.15586/jkcvhl.v11i3.352

PMID 39229326

发布时间 2024-09-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of kidney cancer and VHL

2024年11卷3期

51-58页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of kidney cancer and VHL

2024年11卷3期

51-58页

检索历史清除

Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials.

Journal of kidney cancer and VHL

相似文献

同项目论文

Journal of kidney cancer and VHL

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials.

Journal of kidney cancer and VHL

相似文献

同项目论文

Journal of kidney cancer and VHL

相关期刊

检索历史清除